Increased antiandrogen enzalutamide sensitivity via altering prostate cancer stem cell traits through modulating the androgen receptor-mediated CDR1/circCDR1-AS/miR-1290/BMP4 signaling https://www.nature.com/articles/s41388-025-03482-1
Discover the world at Altruu, The Discovery Engine